Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Sara Deola, MD, PhD, Sidra Medicine, Doha, Qatar, discusses the results of a longitudinal study of immune-transcriptome signatures as a novel approach to understanding graft-versus-host disease (GvHD) and graft-versus-tumor-effect (GVT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).